Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Journal of Hepatology|August 11, 2012
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitroCarlo Pirazzi, Martin Adiels, Maria Antonella Burza, et al.The New England Journal of Medicine|August 24, 2012
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjectsLena M S Carlsson, Markku Peltonen, Sofie Ahlin, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 19, 2012
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individualsMaria Antonella Burza, Carlo Pirazzi, Cristina Maglio, et al.Obesity (Silver Spring, Md.)|March 23, 2013
Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects studyPer-Arne Svensson, Åsa Anveden, Stefano Romeo, et al.ACR Open Rheumatology|August 29, 2025
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid ArthritisTilia Selldén, Kristina Lend, Jon Lampa, et al.The Journal of Clinical Endocrinology and Metabolism|February 19, 2013
The IRS1 rs2943641 variant and risk of future cancer among morbidly obese individualsCristina Maglio, Ulrika Ericson, Maria Antonella Burza, et al.ACR Open Rheumatology|November 4, 2024
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid ArthritisGeorgios K Vasileiadis, Yuan Zhang, Tahzeeb Fatima, et al.Arthritis Research & Therapy|July 27, 2025
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohortTahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, et al.Human Molecular Genetics|March 28, 2014
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cellsCarlo Pirazzi, Luca Valenti, Benedetta Maria Motta, et al.Plos One|August 28, 2025
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritisTilia Selldén, Kerstin Andersson, Inger Gjertsson, et al.Pageof 4